PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 112 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.09 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $108,000 | -65.2% | 42,154 | -73.7% | 0.00% | -71.4% |
| Q2 2022 | $310,000 | -48.6% | 160,420 | -21.0% | 0.01% | -50.0% |
| Q1 2022 | $603,000 | -2.3% | 203,083 | +235.7% | 0.01% | +16.7% |
| Q2 2018 | $617,000 | -88.3% | 60,500 | -71.3% | 0.01% | -84.8% |
| Q3 2017 | $5,285,000 | +605.6% | 210,550 | +440.5% | 0.08% | +618.2% |
| Q1 2017 | $749,000 | +49.5% | 38,953 | +1.2% | 0.01% | +37.5% |
| Q3 2016 | $501,000 | – | 38,503 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |